What is the first-line treatment for an asthma exacerbation?

Prepare for the NBME Form 15 Test with our tailored quiz featuring flashcards and multiple-choice questions, each with hints and detailed explanations. Achieve success with our comprehensive study materials!

Multiple Choice

What is the first-line treatment for an asthma exacerbation?

Explanation:
The first-line treatment for an asthma exacerbation is nebulized albuterol, which is a short-acting beta-agonist (SABA). Albuterol works by relaxing bronchial smooth muscle and dilating the airways, providing rapid relief of bronchospasm. During an asthma exacerbation, patients experience airway inflammation and constriction, leading to difficulty breathing, wheezing, and decreased airflow. Nebulized albuterol delivers medication directly to the lungs, making it effective for quickly relieving symptoms. While systemic corticosteroids are important for reducing inflammation in more severe exacerbations or in patients who do not respond adequately to bronchodilators, they are not the first-line treatment due to their slower onset of action. Oral bronchodilators may provide some relief but are not typically used as the first choice during acute attacks due to their delayed effect compared to nebulized formulations. Intravenous magnesium sulfate may be indicated in severe exacerbations unresponsive to standard treatment but is not a first-line therapeutic agent and is usually reserved for instances of critical exacerbation. Thus, nebulized albuterol is the preferred immediate intervention to rapidly relieve bronchospasm during an asthma exacerbation.

The first-line treatment for an asthma exacerbation is nebulized albuterol, which is a short-acting beta-agonist (SABA). Albuterol works by relaxing bronchial smooth muscle and dilating the airways, providing rapid relief of bronchospasm. During an asthma exacerbation, patients experience airway inflammation and constriction, leading to difficulty breathing, wheezing, and decreased airflow. Nebulized albuterol delivers medication directly to the lungs, making it effective for quickly relieving symptoms.

While systemic corticosteroids are important for reducing inflammation in more severe exacerbations or in patients who do not respond adequately to bronchodilators, they are not the first-line treatment due to their slower onset of action. Oral bronchodilators may provide some relief but are not typically used as the first choice during acute attacks due to their delayed effect compared to nebulized formulations. Intravenous magnesium sulfate may be indicated in severe exacerbations unresponsive to standard treatment but is not a first-line therapeutic agent and is usually reserved for instances of critical exacerbation.

Thus, nebulized albuterol is the preferred immediate intervention to rapidly relieve bronchospasm during an asthma exacerbation.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy